SciELO - Scientific Electronic Library Online

 
vol.31 número2Síndrome metabólico y antipsicóticos de segunda generación índice de autoresíndice de materiabúsqueda de artículos
Home Pagelista alfabética de revistas  

Servicios Personalizados

Revista

Articulo

Indicadores

Links relacionados

  • En proceso de indezaciónCitado por Google
  • No hay articulos similaresSimilares en SciELO
  • En proceso de indezaciónSimilares en Google

Compartir


Revista de la Asociación Española de Neuropsiquiatría

versión On-line ISSN 2340-2733versión impresa ISSN 0211-5735

Resumen

GARCIA-VALDECASAS CAMPELO, José  y  VISPE ASTOLA, Amaia. Money Changers in the Temple: The bio-commercial paradigm hegemony in nowadays Psychiatry. Rev. Asoc. Esp. Neuropsiq. [online]. 2011, vol.31, n.2, pp.321-341. ISSN 2340-2733.  https://dx.doi.org/10.4321/S0211-57352011000200010.

With this paper we pursue a careful consideration about the role and the influence of the pharmaceutical industry on nowadays psychiatry by reviewing and analyzing four capital aspects: the medical and scientific education we receive and provide, as well as its bias; the contemporary psychiatric nosography and its probable evolution considering the oncoming DSM-V; the effectiveness and side effects of the drugs we prescribe, measured by independent studies not provided by the pharmaceutical companies that sell these drugs; and last but not least, the pharmaceutical expenditure we cause with our prescriptions, trying to elucidate whether this expenditure is justified considering the global economic crisis we are living. Finally, we summarize our review and our professional and personal experience in some conclusions to define the relationship between the pharmaceutical industry and the practice of psychiatry, providing, from our humble point of view, some solutions for what we consider a problematic situation of psychiatry.

Palabras clave : Pharmaceutical industry; evidence based medicine; psychiatric nosography; psychiatric education; pharmaceutical expenditure.

        · resumen en Español     · texto en Español     · Español ( pdf )

 

Creative Commons License Todo el contenido de esta revista, excepto dónde está identificado, está bajo una Licencia Creative Commons